Sanofi-Aventis Deutschland GmbH
Operating companyCorporate group: Sanofi Group · HQ: France
Not counted above: 6 file-access requests (R. 262.1(b) RoP), where someone asked to read a case file. View
Sanofi-Aventis Deutschland GmbH has been party to 23 Unified Patent Court cases, 17 times as claimant and 6 times as respondent. The most recent on record is UPC CoA 22/2026 at the Court of Appeal, against STADAPHARM GmbH. Its most recent decision on the merits was in UPC CFI 146/2024 at the Munich Local Division on 12 December 2025: patent revoked.
- 2026-02-12UPC CoA 22/2026Court of Appeal—Sanofi Mature IP v STADAPHARM GmbH
- 2026-02-12UPC CoA 23/2026Court of Appeal—Sanofi Mature IP v Reddy Pharma SAS
- 2026-02-12UPC CoA 24/2026Court of Appeal—Sanofi Mature IP v Zentiva France
- 2026-02-12UPC CoA 25/2026Court of Appeal—Sanofi-Aventis Deutschland GmbH v STADA Arzneimittel AG
- 2026-01-12UPC CFI 106/2026Munich LDCosts onlySanofi Mature IP v STADAPHARM GmbH
- 2026-01-12UPC CFI 108/2026Munich LD—STADA Arzneimittel AG v Sanofi-Aventis Deutschland GmbH
- 2026-01-12UPC CFI 92/2026Munich LD—Sanofi Mature IP v Reddy Pharma SAS
- 2026-01-12UPC CFI 98/2026Munich LD—Sanofi Mature IP v Zentiva France
- 2025-12-23UPC CFI 2220/2025Munich CD—Amgen Inc. v Sanofi-Aventis Deutschland GmbH
- 2025-01-21UPC APP 3214/2025Munich CDFile-access requestName not displayed for GDPR reasons. Represented by Sture RYGAARD v Sanofi-Aventis Deutschland GmbH